Lexeo Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.45-$10.38 |
Market Cap | $661.2M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$65.9M |
Diluted EPS | -$2.50 |
News
See moreYahoo Finance • 19 days ago
Lexeo Therapeutics Reports Third Quarter 2025 Financial Results and Operational Highlights
Yahoo Finance • 21 days ago
Is Lexeo Therapeutics (LXEO) One of Billionaire Daniel Sundheim’s Stock Picks with Huge Upside Potential
Yahoo Finance • last month
Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares in the Public Offering
Yahoo Finance • last month
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
About
CEO | Mr. R. Nolan Townsend |
CFO | Mr. Louis Tamayo |
Address | 345 Park Avenue South, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |
